Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi

Journal of Infection in Developing Countries

Volumn 6, Issue 1, 2012, Pages 33-39

  Ndung'u, Perpetual Wangui ^a   Kariuki, Samuel ^b   Ng'ang'a, Zipporah ^a   Revathi, Gunturu ^c  

^a JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c AGA KHAN UNIVERSITY   (Kenya)

Author keywords

Multidrug resistance; Resistance patterns; Susceptibility tests; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; HUMAN; KENYA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84855990679     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2281     Document Type: Article

References (26)

1. WHO (2010) Global tuberculosis control report. Available http://www.who.int/tb/publication/global_report/2010/en/index.html. Accessed 20 November 2010.
2. Ministry of Health, Kenya (2007) National Leprosy and tuberculosis program (NLTP). Annual report. Available http://www.nltp.co.ke/docs/Annual_Report_2007.pdf. Accessed 10 September 2010.
3. WHO (2009) Global tuberculosis control report. Available http://www.who.int/tb/publications/global_report 2009/pdf/full_report.pdf. Accessed10 September 2010.
4. Githui WA, Juma ES, van Gorkom J, Kibuga D, Othiambo J, Drobniewski F (1998) Antituberculosis drug resistance surveillance in Kenya. Int J Tuberc Lung Dis 2: 499-505.
5. USAID (2009) Tuberculosis profile. Available Http://www.itnhealth.net/medicalfiles/cme_series/module-004-Havard/hiv_tb/assets/reports/USAID-kenya-2009.pdf. Accessed 8 November 2010.
6. WHO (2008) Antituberculosis drug resistance in the world report NO. 4 prevalence and trends Geneva. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Available http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.394_eng.pdf. Accessed 10 September 2010.
7. Githui WA, Hawken MP, Juma ES, Godfrey-Faussett P, Swai OB, Kibuga DK, Porter JD, Wilson SM, Drobniewski FA (2000) Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis 4: 947-955.
8. Taha N, Hamed A, Qurechi JA, Ahmad B, Abraham S (2009) Rifampicin resistance profile of Mycobacterium tuberculosis isolated from human patients. Proc Pakistan Acad Sc 46: 131-136.
9. Willy U, Fernand M, Eduardo V, Gernard M, Candida M, Ronald B, Elma S, Wafaie F (2008) Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. BMC (Research Notes) 1: 58.
10. Uplekar MW, Rangan S, Weiss MG, Ogden J, Borgdorff MW (2001) Attention to gender issues in tuberculosis control. Int J Tuberc Lung Dis 5: 220-224.
11. Lonnroth K, Juramillo E, Williams B, Dye C, Raviglione M (2009) Drivers of tuberculosis epidemics. The role of risk factors and social determinants. Social science and medicine 68: 2240-2246. Available http://www.sciencedirect.com/science/article/pii/SO2777953609002111. Accessed 8 November 2011.
12. Rajeswari R, Chandrasekaran V, Suhedev M, Sivasubramaniam S, Sudha G, Rehu G (2002) Factors associated with patient and health system delays in diagnosis of tuberculosis in South India. Int J Tub Lung Dis 6: 789-795.
13. Bruchfeld J, Aderaye G, Berggren Palme I, Bjorvatan B, Gebremichael S, Lindquist L (2002) Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary TB patients with and without HIV infection. J Clin microb 40: 1636-1643.
14. Eyob G, Guebrexabher H, Lemma E, Wolday D, Gebeyehu M, Abate G, Rigouts L, van Soolingen D, Fontanet A, Sanders E, Dorigo-Zetsema JW (2004) Drug susceptibility of Mycobacterium tuberculosis in HIV infected and uninfected Ethiopians and its impact on outcome after 24 months of follow-up. Inter J Tuberc Lung Dis 8: 1388-1391.
15. Lee JH, Chang JH (2001) Drug resistance tuberculosis in tertiary referral teaching hospital in Korea. Korean J Intern Med 16: 173-179.
16. Churchyard GJ, Corbett EL, Kleinschmidt I, Mulder D, DeCock KM (2000) Drug resistance tuberculosis in South Africa gold miners: Incidence and association factors. Inter J Tuberc Lung Dis 4: 433-440.
17. Hellen S, Juan D, Roy M, Sabine R, Dennis F, Ian S, Darebay D, Yared K, Mohamed A (2004) Multidrug resistance in Central Asia. Emerg Infec Dis 10: 1210-1215.
18. Githui WA, Kwamanga D, Chakaya JM, Karimi FG, Waiyaki PG (1993) Anti-tuberculosis initial drug resistance of Mycobacterium tuberculosis in Kenya: a ten-year review. East Afr Med J 70:609-612.
19. Kassu D, Daniel A, Eshatu L, Mekdes GM, Benium F (2008) Drug susceptibility of Mycobacterium tuberculosis isolates from smear negative pulmonary tuberculosis patients, Addis Ababa, Ethiopia. Ethiop J Health Dev 22: 212-215.
20. Van Deun A, Aung KJ, Chowdhury S, Saba S, Paukay A, Ashraf A, Rigout L, Fissette K, Portael F (1999) Drug susceptibility of Mycobacterium tuberculosis in rural area of Banglandesh and its relevance to the national treatment regimes. Inter J Tuberc Lung Dis 3: 143-148.
21. Magana-Arachi DN, Pirera AJ, Senarathe V, Chandrasekharan NV (2010) Patterns of drug resistance and RFLP analysis of Mycobacterium tuberculosis strains isolated from recurrent tuberculosis patients in Sri Lanka. South East Asian J Trop Med Public Health 41: 583-589.
22. Nunes EA, DeCapitani EM, Coelho E, Panunto AC, Joaquim OA, Ramos MC (2008) Mycobacterium tuberculous and non tuberculous mycobacterium isolates among patients with recent HIV infection in Mozambique. J Bras Pneumol 34: 10.
23. Abate G, Miorner H (1998) Susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to amoxicillin in combination with clavulanic acid and ethambutol. J Antimicrob Chemother 42: 735-740.
24. Crofton J, Chaulet P, Maher D (1997) Guidelines for management of drug resistant TB. Available http://whqlibdoc.who.int/hq/1997/who_tb_96.210_(rev.1).pdf. Accessed 11 August 2009.
25. Streicher EM, Warren RM, Kewley C, Simpson J, Rastogi N, Sola C, Van der Spuy GD, van Helden PD, Victor TC (2004) Genotypic and phenotypic characterization of drug resistant mycobacterium tuberculosis isolates from rural districts of Western Cape Province of South Africa. J clin microb 42: 891-894.
26. Zignol M, Hosseini MS, Wright A, Weezenbeck CL, Nunn P, Watt CJ, Williams BG, Dye C (2006) Global incidence of multidrug resistant tuberculosis. J Infect Dis 194: 479-485.